Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03278119

Sleep Aging and Risk for Alzheimer's 2.0

Sleep Aging and Risk for Alzheimer's Resubmission 2.0

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
158 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
55 Years – 75 Years
Healthy volunteers
Accepted

Summary

Age-related sleep changes and common sleep disorders like obstructive sleep apnea (OSA) may increase amyloid burden and represent risk factors for cognitive decline in the elderly. We will directly interrogate the brain using a 2-night nocturnal polysomnography (NPSG) and amyloid deposition using C-PiB PET/MR both at baseline and at the 24-month follow-up. This study has the potential to identify the mechanisms by which age-related sleep changes contribute to AD neurodegeneration in cognitively normal elderly, the group that could profit the most from sleep preventive strategies.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPET Scan and nocturnal polysomnographyAmyloid PET scans will be used to assess amyloid burden in the brain, and nocturnal polysomnography will be used to assess sleep and cardiopulmonary variables

Timeline

Start date
2018-05-01
Primary completion
2026-12-25
Completion
2026-12-25
First posted
2017-09-11
Last updated
2026-03-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03278119. Inclusion in this directory is not an endorsement.